Rapid Screening of MCM Efficacy Against SARS-CoV-2 Pseudoviruses with Spike Variants

Closed Solicitation Posted

This opportunity was awarded. See the award notice from .

Solicitation number
75A50121R00033
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

NAICS code
621511 Medical Laboratories

Notice details come from SAM.gov. Updated .

About this opportunity

This solicitation from the Department of Health and Human Services seeks laboratory assay testing services to evaluate medical countermeasures against SARS-CoV-2 pseudoviruses. The base period requires validation documentation for a pseudovirus neutralization assay, production of up to 250 pseudoviruses, and testing of up to 250 pseudoviruses and 100 medical countermeasures. Responses will be evaluated based on technical capability, price, and past performance, with the award being made as a firm fixed-price contract with payable milestones. Responses are due by 3:00pm on May 7, 2021.

There is no set-aside designation for this procurement. The primary NAICS code is 541715 and PSC code is R425. The base period involves validating the assay, producing and testing 250 pseudoviruses, with 26 options to test additional pseudoviruses and prepare manuscripts. Testing will take place at the offeror's laboratory facility.

Notice text

2 versions

Update #2 · Latest ·

This is a re-issuance of a solicitation.  The small business set-aside is disolved in accordance with FAR 19.502-10 Automatic dissolution of a small business set-aside.

See attached CSS with Attachments.

Update #1 ·

See attached CSS with Attachments.

Files

Notice history

Notice Type Posted
Rapid Screening of MCM Efficacy Against SARS-CoV-2 Pseudoviruses with Spike Variants Award Award Notice
This notice Latest solicitation Solicitation

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors